ROS/KRAS/AMPK Signaling Determines Gemcitabine-Induced Pancreatic Cancer Stem-Like Cell Property in Vitro

Oncotarget - United States
doi 10.18632/oncotarget.24081
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors
Publisher

Impact Journals, LLC

Related search

JNK Suppression of Chemotherapeutic Agents-Induced ROS Confers Chemoresistance on Pancreatic Cancer Stem Cells

Oncotarget
Oncology
2014English

MST1 Suppresses Pancreatic Cancer Progression via ROS Induced Pyroptosis

Molecular Cancer Research
Cancer ResearchOncologyMolecular Biology
2019English

Signaling via 1 Integrins and Mitogen-Activated Protein Kinase Determines Human Epidermal Stem Cell Fate in Vitro

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
1999English

Stem Cell–directed Therapies in Pancreatic Cancer

Current Problems in Cancer
Cancer ResearchOncology
2013English

A Stem Cell Medium Containing Neural Stimulating Factor Induces a Pancreatic Cancer Stem-Like Cell-Enriched Population

International Journal of Oncology
Cancer ResearchOncology
2014English

Establishment and Characterization of the Gemcitabine‑resistant Human Pancreatic Cancer Cell Line SW1990/gemcitabine

Oncology Letters
Cancer ResearchOncology
2019English

The Role of GLI-SOX2 Signaling Axis for Gemcitabine Resistance in Pancreatic Cancer

Oncogene
Cancer ResearchGeneticsMolecular Biology
2018English

Induced Pluripotent Stem (iPS) Cell–derived Pancreatic Β-Like Cells for Treating Diabetes

Science-Business eXchange
2010English

Targeted Degradation of KRAS by an Engineered Ubiquitin Ligase Suppresses Pancreatic Cancer Cell Growth in Vitro and in Vivo

Molecular Cancer Therapeutics
Cancer ResearchOncology
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy